Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

WeRide (WRD) Cash & Equivalents (2022 - 2025)

Historic Cash & Equivalents for WeRide (WRD) over the last 4 years, with Q3 2025 value amounting to $484.9 million.

  • WeRide's Cash & Equivalents rose 21999.85% to $484.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $484.9 million, marking a year-over-year increase of 21999.85%. This contributed to the annual value of $595.8 million for FY2024, which is 15348.41% up from last year.
  • As of Q3 2025, WeRide's Cash & Equivalents stood at $484.9 million, which was up 21999.85% from $535.5 million recorded in Q2 2025.
  • WeRide's 5-year Cash & Equivalents high stood at $594.2 million for Q4 2024, and its period low was $151.5 million during Q3 2024.
  • In the last 4 years, WeRide's Cash & Equivalents had a median value of $399.5 million in 2022 and averaged $389.5 million.
  • In the last 5 years, WeRide's Cash & Equivalents plummeted by 2654.0% in 2023 and then soared by 21999.85% in 2025.
  • Over the past 4 years, WeRide's Cash & Equivalents (Quarter) stood at $314.1 million in 2022, then fell by 26.54% to $230.7 million in 2023, then soared by 157.56% to $594.2 million in 2024, then dropped by 18.39% to $484.9 million in 2025.
  • Its Cash & Equivalents was $484.9 million in Q3 2025, compared to $535.5 million in Q2 2025 and $575.6 million in Q1 2025.